Our Frank & Fearless series invites brilliant individuals who are pushing the boundaries of science, health, and innovation to join us and share their inspiring journeys – both personal and professional. For this occasion, we'll have the pleasure of hosting Dr Kath Giles in Perth later this month.
Kath is currently a Director and CEO of OncoRes Medical and Director of Respirion Pharmaceuticals. Kath joined Brandon Capital Partners in 2012. Before this, Kath was an Investment Manager with Perth-based Stone Ridge Ventures, a fund manager specialising in seed-to-early stage technology investment. She has startup experience in medical apps, diagnostics and fitness devices.
Hear the story behind her achievements, the challenges she's faced, and the insights she has gained along her remarkable journey at our next ‘Frank and Fearless’ session on 25 October in Perth.
Thank you to the Western Australian Department of Health for their support and the WA Life Sciences Innovation Hub for sharing this month's spotlight as we partner on this event with the WA MTP Sector Spotlight Series.
Frank and Fearless - Session 2